Evidence map›Paper›PMID 14634621›Full record

ReviewOncogene2003

The Bcl-2 family: roles in cell survival and oncogenesis.

Suzanne Cory, David C S Huang, Jerry M Adams

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Oncogene, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03136497 (Phase Ib Dose Finding Study of ABT-199), which is not on this map. Cited by 511 papers.

0numbers the graph read from it
0cells of the map it votes in
511citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03136497 phase1terminatednot on this mapstarted 2017, after this paper: background citation

Phase Ib Dose Finding Study of ABT-199 (A-1195425.0) Plus Ibrutinib (PCI-32765) and Rituximab in Patients With Relapsed/Refractory Diffuse Large B-cell NHL (DLBCL)

TypeinterventionalSponsorHackensack Meridian HealthRan2017 to 2020Enrolled10ConditionsRelapsed Diffuse Large B-Cell Lymphoma, Refractory Diffuse Large B-Cell LymphomaArms400mg ABT-199, Ibrutinib, Rituximab, 800mg ABT-199
3 · Its place in the literature

Who cites it

511 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Unveiling the Pharmacological Potential ofInternational journal of molecular sciences · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Mitoquinone Can Effectively Improve the Quality of Thawed Boar Sperm.Animals : an open access journal from MDPI · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

451 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Suzanne CoryThe Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville 3050, Victoria, Australia. cory@wehi.edu.au
David C S Huang
Jerry M Adams

Funding

ONCOGENE-INDUCED LEUKEMOGENESIS IN TRANSGENIC MICER01CA043540 · NCI · WALTER AND ELIZA HALL INST MEDICAL RES · PI CORY, SUZANNE · 1987 to 2009
$1.7M
MECHANISMS IN THE REGULATION OF APOPTOSISR01CA080188 · NCI · WALTER AND ELIZA HALL INST MEDICAL RES · PI ADAMS, JERRY M · 1999 to 2006
$1.1M
NCI NIH HHS CA43540NCI NIH HHS CA80188
6 · The paper itself

Abstract

Apoptosis, the cell-suicide programme executed by caspases, is critical for maintaining tissue homeostasis, and impaired apoptosis is now recognized to be a key step in tumorigenesis. Whether a cell should live or die is largely determined by the Bcl-2 family of anti- and proapoptotic regulators. These proteins respond to cues from various forms of intracellular stress, such as DNA damage or cytokine deprivation, and interact with opposing family members to determine whether or not the caspase proteolytic cascade should be unleashed. This review summarizes current views of how these proteins sense stress, interact with their relatives, perturb organelles such as the mitochondrion and endoplasmic reticulum and govern pathways to caspase activation. It briefly explores how family members influence cell-cycle entry and outlines the evidence for their involvement in tumour development, both as oncoproteins and tumour suppressors. Finally, it discusses the promise of novel anticancer therapeutics that target these vital regulators.

Indexed as

ApoptosisCell SurvivalAnimalsCaspasesCell CycleHumansNeoplasmsPeptide FragmentsProto-Oncogene ProteinsProto-Oncogene Proteins c-bcl-2Bax protein (53-86)CaspasesPeptide FragmentsProto-Oncogene ProteinsProto-Oncogene Proteins c-bcl-2

Identifiers

PMID14634621

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.